Inhibitiont of Obazema on Proliferation of Gastric Cancer BGC-823 Cells and Its Mechanism

[Objectives]This study aimed to investigate the inhibiting effect of Obazema on proliferation of gastric cancer BGC-823 cells and its mechanism.[Methods]BGC-823 cells were treated with high,medium and low concentrations of drug-containing serum(0.316%,0.158%and 0.079%)for 0,48,72 and 96 h,respectively.Then,the proliferation of the cells was detected with CCK-8 method,and the expression of related proteins,B lymphocytoma-2(Bcl-2),phosphorylated protein kinase B(p-Akt),protein kinase B(Akt)and glyceraldehyde-3-phosphate dehydrogenase(GAPDH),was detected using Western blotting.[Results]The proliferation of the BGC-823 cells was significantly inhibited with different doses of Boenninghausenia albiflora(Hook.)Reichb.ex Meisn.var.albiflora(CH)and B.sessilicarpa Lévl.(S)(P<0.01),in dose-dependent and time-dependent manners.The inhibition of high-dose S on cell proliferation was similar to that of CTX 48 h after administration;the inhibition of high-dose CH on cell proliferation was significantly stronger than that of CTX(P<0.01);different doses of drug administration groups significantly inhibited the expression of p-Akt and Bcl-2 in the BGC-823 cells;the inhibition of high-dose CH on the expression of P-Akt and Bcl-2 and the inhibition of medium-dose CH on the expression of Bcl-2 were significantly stronger than that of CTX(P<0.05,P<0.01),in a certain dose-dependent manner;at the same dose,the inhibition of CH on the expression of the proteins was stronger than that of S(P<0.05,P<0.01);administration of S and CH significantly inhibited the expression of GAPDH compared with CTX(P<0.05,P<0.01).[Conclusions]Obazema has the capacity to inhibit the proliferation of BGC-823 cells.The mechanism may be achieved by inhibiting the expression of p-Akt and Bcl-2,and GAPDH may be the target gene of its anti-tumor mechanism.The inhibiting effect of CH on BGC-823 cells was more significantly than that of S.

Study on Infrared Fingerprints of Different Sources of Yi Medicine Ebazema

[Objectives] To establish infrared fingerprints of different parts of Boenninghausenia albiflora(Hook.) Reichb.ex Meissn. and Boenninghausenia sessilicarpa Levl.(two sources of Yi medicine Ebazema) and analyze the similarity between them. [Methods] The infrared fingerprints of powder of B. albiflora(Hook.) Reichb.ex Meissn. and B. sessilicarpa Levl. were measured, and the common peak rate and variation peak rate of six samples were calculated to establish the sequence analysis method of common peak rate. [Results] There was a very high common peak rate(≥81.3%) and a very low variation peak rate(≤15.4%) between S1 and S4 as well as S2 and S6. There was a low common peak rate between S1 and S3 as well as S3 and S4, and the common peak rate was 42.9% and 47.6% respectively. There was a low common peak rate(≤47.6%) and a high variation peak rate(≥100.0%) between S1 and S3 as well as S3 and S4. [Conclusions] The method is simple and convenient to operate, can quickly identify different parts used as medicine of B. albiflora(Hook.) Reichb.ex Meissn. and B. sessilicarpa Levl.(two sources of Yi medicine Ebazema), and provide a new method to judge whether the two are equivalent when being used as medicine and quality evaluation.